Financial Metrics Exploration: Understanding Neogenomics Inc (NEO) Through Ratios

Kevin Freeman

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

The closing price of Neogenomics Inc (NASDAQ: NEO) was $7.86 for the day, down -0.06% from the previous closing price of $7.87. In other words, the price has decreased by -$0.06 from its previous closing price. On the day, 1.16 million shares were traded. NEO stock price reached its highest trading level at $7.945 during the session, while it also had its lowest trading level at $7.65.

Ratios:

Our analysis of NEO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.58 and its Current Ratio is at 3.92. In the meantime, Its Debt-to-Equity ratio is 0.48 whereas as Long-Term Debt/Eq ratio is at 0.48.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 06 ’25 when Sherman Jeffrey Scott bought 20,000 shares for $5.62 per share. The transaction valued at 112,322 led to the insider holds 188,332 shares of the business.

Zook Anthony P. bought 17,900 shares of NEO for $99,954 on Aug 06 ’25. The Chief Executive Officer now owns 38,066 shares after completing the transaction at $5.58 per share. On May 27 ’25, another insider, Kelly Michael Aaron, who serves as the Director of the company, bought 5,000 shares for $7.60 each. As a result, the insider paid 38,000 and bolstered with 5,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NEO now has a Market Capitalization of 1015989824 and an Enterprise Value of 1264067840. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.47 while its Price-to-Book (P/B) ratio in mrq is 1.19. Its current Enterprise Value per Revenue stands at 1.834 whereas that against EBITDA is -162.56.

Stock Price History:

The Beta on a monthly basis for NEO is 1.61, which has changed by -0.45724136 over the last 52 weeks, in comparison to a change of 0.15101504 over the same period for the S&P500. Over the past 52 weeks, NEO has reached a high of $19.11, while it has fallen to a 52-week low of $4.72. The 50-Day Moving Average of the stock is 14.16%, while the 200-Day Moving Average is calculated to be -20.08%.

Shares Statistics:

NEO traded an average of 2.45M shares per day over the past three months and 2140600 shares per day over the past ten days. A total of 128.68M shares are outstanding, with a floating share count of 125.06M. Insiders hold about 3.19% of the company’s shares, while institutions hold 97.27% stake in the company. Shares short for NEO as of 1756425600 were 5231888 with a Short Ratio of 2.41, compared to 1753920000 on 5018485. Therefore, it implies a Short% of Shares Outstanding of 5231888 and a Short% of Float of 5.58.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.